Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Oklahoma City, OK
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Worth, TX
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Chapel Hill, NC
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Richardson, TX
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Richardson, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Chandler, AZ
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Corona, CA
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Corona, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Riverside, CA
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Washington,
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Aventura, FL
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Pinellas Park, FL
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Owensboro, KY
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Charles, MO
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Saint Charles, MO
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Omaha, NE
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Princeton, NJ
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Princeton, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Amherst, NY
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Amherst, NY
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Manhasset, NY
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Manhasset, NY
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Allentown, PA
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Allentown, PA
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Charlottesville, VA
A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Orlando, FL
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Atlanta, GA
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Garden Grove, CA
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Lake Charles, LA
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Berlin, NJ
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Dayton, OH
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Charlottesville, VA
A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Birmingham, AL
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Dothan, AL
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Harmonex Neuroscience Research
mi
from
Dothan, AL
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
NoesisPharma
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Little Rock, AR
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Rogers, AR
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Anaheim, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
California Pharmaceutical Research Institute, Inc
mi
from
Anaheim, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Beverly Hills, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Southern California Research
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Costa Mesa, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Culver City, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
ProScience Research Group
mi
from
Culver City, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Garden Grove, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Glendale, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Imperial, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sun Valley Research Center
mi
from
Imperial, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Lemon Grove, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Synergy Clinical Research Center of Escondido
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Los Alamitos, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Oakland, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Oceanside, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Orange, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Panorama City, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Asclepes Research Centers
mi
from
Panorama City, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Redlands, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Anderson Clinical Research
mi
from
Redlands, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
Riverside, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
CITRIALS
mi
from
Riverside, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
San Diego, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
San Diego, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
PCSD - Feighner Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
mi
from
San Marcos, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
mi
from
San Marcos, CA
Click here to add this to my saved trials